What is the LifeWrap NASG?


About the LifeWrap NASG

The Non-Pneumatic Anti-Shock Garment (NASG) is a lightweight (1.5kg), washable and reusable first aid compression device made of neoprene fastened with velcro over a foam compression ball.  Once in place, the LifeWrap NASG applies enough circumferential counter pressure to decrease blood loss and reverse shock by increasing blood pressure to the heart, brain, and lungs.  In so doing, it reverses hypovolaemic shock resulting from Obstetric Haemorrhage, and has proven effective in stabilising patients for up to 3 days, while patients are transported to a health centre with the ability to administer blood transfusions and provide definitive medical or surgical interventions.

We believe so much in, and are so committed to increasing access to the LifeWrap NASG and the results it can achieve,  that we will donate a percentage of proceeds from the sales of all LifeWrap NASGs, to make FREE LifeWraps available to specific causes.


Postpartum Haemorrhage (PPH) mortality

Postpartum Haemorrhage (PPH), commonly defined as blood loss of 500mls or more within 24hrs after birth, is the leading cause of maternal mortality in most low-income countries.  Approximately 2% of all pregnancies are affected by PPH and nearly one quarter (1) of the 287,000 maternal deaths globally (2) are associated with it.  Most of these deaths occur within the first 24 hours of delivery (3) as a result of complications in the third stage of labor.  When uteronic drugs are unavailable or are ineffective in preventing PPH, women can quickly undergo heavy bleeding and enter into hypovolaemic shock.  The required medical interventions to treat such conditions are often not available in low-resource settings, where deliveries can occur far from health facilities, or where facilities do not have the necessary resources.

1) WHO Recommendations for the prevention and Treatment of Post Partum Haemorrhage. Available at http://www.who.int/reproductivehealth/publications/maternal_perinatal_health/9789241548502/en/ (November 2012). 2) Institute for Health Metrics and Evaluation. 2010; United Nations "Trends in Maternal Mortality:1990 to 2010". 2012. 3) PSI. "Accelovate Market Analysis for Magnesium Sulfate, Misoprostol and Oxytocin." 2012